These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 2508593

  • 41. [Predictive factors of induction of ventricular arrhythmia under amiodarone].
    Bourret N, Kirkorian G, Chevalier P, Bellon C, Richalet C, Bouchayer D, Bonnefoy E, Touboul P.
    Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1277-81. PubMed ID: 8952825
    [Abstract] [Full Text] [Related]

  • 42. Control of recurrent supraventricular tachycardia with amiodarone hydrochloride.
    Swan JH, Chisholm AW.
    Can Med Assoc J; 1976 Jan 10; 114(1):43-4. PubMed ID: 943223
    [Abstract] [Full Text] [Related]

  • 43. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia.
    Wichter T, Borggrefe M, Haverkamp W, Chen X, Breithardt G.
    Circulation; 1992 Jul 10; 86(1):29-37. PubMed ID: 1617780
    [Abstract] [Full Text] [Related]

  • 44. [Repetitive ventricular tachycardia. A type of arrhythmia with good prognosis].
    Nielsen H, Pietersen AH.
    Ugeskr Laeger; 1989 Aug 14; 151(33):2089-90. PubMed ID: 2505421
    [Abstract] [Full Text] [Related]

  • 45. Arrhythmogenic effects of antiarrhythmic drugs.
    Furlanello F, Dal Forno P, Cozzi F, Bettini R.
    Cardiologia; 1990 Jan 14; 35(1 Suppl):73-8. PubMed ID: 2128207
    [No Abstract] [Full Text] [Related]

  • 46. Value of Holter monitoring in predicting long-term efficacy and inefficacy of amiodarone used alone and in combination with class 1A antiarrhythmic agents in patients with ventricular tachycardia.
    Kim SG, Felder SD, Figura I, Johnston DR, Waspe LE, Fisher JD.
    J Am Coll Cardiol; 1987 Jan 14; 9(1):169-74. PubMed ID: 3794093
    [Abstract] [Full Text] [Related]

  • 47. Clinical and electrophysiologic effects of flecainide in patients with refractory ventricular tachycardia.
    Capparelli EV, Kluger J, Regnier JC, Chow MS.
    J Clin Pharmacol; 1988 Mar 14; 28(3):268-75. PubMed ID: 3129456
    [Abstract] [Full Text] [Related]

  • 48. His bundle tachycardia--arrhythmogenic and antiarrhythmic effects of therapy.
    Wren C, Campbell RW.
    Eur Heart J; 1987 Jun 14; 8(6):647-50. PubMed ID: 3113958
    [Abstract] [Full Text] [Related]

  • 49. Slowing of ventricular tachycardia as a possible endpoint for serial drug testing at electrophysiological study.
    Handlin LR, Brodine WN, Gibbs H, Vacek JL.
    Pacing Clin Electrophysiol; 1992 Jun 14; 15(6):864-9. PubMed ID: 1376898
    [Abstract] [Full Text] [Related]

  • 50. Effect of intravenous and oral flecainide on ventricular tachycardia.
    Ward DE, Cheesman M, Dancy M.
    Int J Cardiol; 1986 Mar 14; 10(3):251-62. PubMed ID: 3957470
    [Abstract] [Full Text] [Related]

  • 51. Flecainide in the treatment of nonsustained ventricular tachycardia.
    Lal R, Chapman PD, Naccarelli GV, Schechtman KB, Rinkenberger RL, Troup PJ, Kim SS, Dougherty AH, Ruffy R.
    Ann Intern Med; 1986 Oct 14; 105(4):493-8. PubMed ID: 3752754
    [Abstract] [Full Text] [Related]

  • 52. [Congenital junctional ectopic tachycardia. Pharmacologic management during infancy].
    Benjamín MN, Infante J, Olmedo J, Abello M, Moltedo JM.
    Medicina (B Aires); 2011 Oct 14; 71(6):521-4. PubMed ID: 22167724
    [Abstract] [Full Text] [Related]

  • 53. Experience with electrophysiologically guided therapy of ventricular tachycardia with flecainide: summary of long-term follow-up.
    Anderson JL.
    Am J Cardiol; 1984 Feb 27; 53(5):79B-86B. PubMed ID: 6695820
    [Abstract] [Full Text] [Related]

  • 54. Rapid suppression of flecainide-induced incessant ventricular tachycardia with high-dose intravenous amiodarone.
    Sagie A, Strasberg B, Kusniec J, Sclarovsky S, Rechavia E, Agmon J.
    Chest; 1988 Apr 27; 93(4):879-80. PubMed ID: 3127126
    [Abstract] [Full Text] [Related]

  • 55. Treatment of resistant ventricular tachycardia by endocavitary fulguration associated with anti-arrhythmic therapy.
    Fontaine G, Tonet JL, Frank R, Touzet I, Dubois-Rande JL, Gallais Y, Grosgogeat Y.
    Eur Heart J; 1987 Aug 27; 8 Suppl D():133-41. PubMed ID: 3678253
    [Abstract] [Full Text] [Related]

  • 56. Occurrence of exercise-induced and spontaneous wide complex tachycardia during therapy with flecainide for complex ventricular arrhythmias: a probable proarrhythmic effect.
    Anastasiou-Nana MI, Anderson JL, Stewart JR, Crevey BJ, Yanowitz FG, Lutz JR, Johnson TA.
    Am Heart J; 1987 May 27; 113(5):1071-7. PubMed ID: 3107362
    [Abstract] [Full Text] [Related]

  • 57. Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone.
    Kaski JC, Girotti LA, Messuti H, Rutitzky B, Rosenbaum MB.
    Circulation; 1981 Aug 27; 64(2):273-9. PubMed ID: 6788399
    [Abstract] [Full Text] [Related]

  • 58. [Isolated ventricular tachycardia without patent cardiopathy].
    Sébastien P, Waynberger M, Beaufils P, Motté G, Slama R, Bouvrain Y.
    Arch Mal Coeur Vaiss; 1976 Sep 27; 69(9):919-28. PubMed ID: 825063
    [Abstract] [Full Text] [Related]

  • 59. Antiarrhythmic Agent Induced Ventricular Tachycardia.
    Agrawal Y, Kalavakunta JK, Gupta V.
    Am J Ther; 2017 Sep 27; 24(4):e487. PubMed ID: 27574940
    [No Abstract] [Full Text] [Related]

  • 60. [Non-invasive evaluation of the effectiveness of flecainide in the treatment of ventricular extrasystole arrhythmia].
    Mangini SG, Mastropasqua F, Lagioia R, Ricci A, Scrutinio D, Rizzon P.
    Cardiologia; 1986 Jun 27; 31(6):443-51. PubMed ID: 2434229
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.